ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |
Key Client Fiduciary Advisors, LLC | 316,325 | $246,734 | 0.15% |
DAFNA Capital Management LLC | 351,064 | $273,830 | 0.08% |
Rock Springs Capital Management LP | 2,787,845 | $2,174,519 | 0.06% |
Baker Brothers Advisors | 10,969,282 | $8,556,040 | 0.05% |
Artal Group S.A. | 1,133,775 | $884 | 0.04% |
Black Maple Capital Management LP | 69,839 | $54,474 | 0.04% |
Redmile Group, LLC | 715,607 | $558,173 | 0.03% |
HARBOR CAPITAL ADVISORS, INC. | 134,415 | $104,844 | 0.02% |
Marquette Asset Management, LLC | 99,349 | $77,493 | 0.02% |
X-Square Capital, LLC | 26,771 | $25 | 0.02% |
External links
This page lists ADAPTIMMUNE THERAPEUTICS PLC's shareholders in Q3 2023. To view ADAPTIMMUNE THERAPEUTICS PLC's shareholder history, click here.